Navamedic Q3 2024: Business remains strong in quarter impacted by cyclical nature of the business

Oslo, 31 October 2024 – In the third quarter of 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, delivered revenues of NOK 123.1 million compared to 141.0 in the corresponding

Sammanhang: ...Oslo, 31 October 2024 – In the third quarter of 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, delivered revenues of NOK 123.1 million compared to 141.0 in the corresponding quarter last year. ...

Omnämnda platser: Oslo.

Navamedic Q2 och H1 2024: Den stabila tillväxten fortsätter och stöds av ett nytt licensavtal

Oslo, 16 augusti 2024 – Under första halvåret 2024 levererade Navamedic ASA (OSE: NAVA), ett nordiskt läkemedelsföretag och leverantör av produkter till sjukhus och apotek, en omsättning på 277,2 miljoner NOK, en ökning med 12,8 procent jämfört med sammaperiod

Sammanhang: ...Oslo, 16 augusti 2024 – Under första halvåret 2024 levererade Navamedic ASA (OSE: NAVA), ett nordiskt läkemedelsföretag och leverantör av produkter till sjukhus och apotek, en omsättning på 277,2 miljoner NOK, en ökning med 12,8 procent jämfört med samma period förra året. ...

Omnämnda platser: Oslo, Europa.

Navamedic Q2 and H1 2024: Stable growth continues and is supported by a new licensing and supply agreement

Oslo, 16 August 2024 – In first half of 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, delivered revenues of NOK 277.2 million, up 12.8 per cent from the corresponding period

Sammanhang: ...Oslo, 16 August 2024 – In first half of 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, delivered revenues of NOK 277.2 million, up 12.8 per cent from the corresponding period last year. ...

Omnämnda platser: Oslo.

Navamedic and Orion Corporation sign License & Supply Agreement for Flexilev® in Europe

Sammanhang: ...Navamedic and Orion Corporation sign License & Supply Agreement for Flexilev® in Europe...

Omnämnda platser: Navamedic.

Navamedic ASA: Broad launch for Eroxon® in Sweden today

Oslo, 6 May 2024 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies has launched Eroxon® in Sweden. Eroxon® is clinically proven and considered a breakthrough in treatment of erectile

Sammanhang: ...Oslo, 6 May 2024 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies has launched Eroxon® in Sweden. ...

Omnämnda platser: Oslo.

Navamedic Q1 2024: Successful product launch and steady operational progress

Sammanhang: ...Navamedic Q1 2024: Successful product launch and steady operational progress...

Navamedic welcomes new shareholders

Sammanhang: ...Navamedic welcomes new shareholders...

Omnämnda platser: Navamedic.

Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives

Oslo, 15 February 2024 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announced its results for the fourth quarter and for the full year 2023. Revenues for the year was

Sammanhang: ...Oslo, 15 February 2024 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announced its results for the fourth quarter and for the full year 2023. ...

Omnämnda platser: Oslo, Navamedic.

Navamedic ASA: Invitation to 2023 4th quarter presentation

Sammanhang: ...Navamedic ASA: Invitation to 2023 4th quarter presentation...

Navamedic ASA: Renewed contract signed with Vitaflo International Limited

Oslo, 21 December 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announces it has renewed its contract with Vitaflo International Limited (Vitaflo International),

Sammanhang: ...Oslo, 21 December 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announces it has renewed its contract with Vitaflo International Limited (Vitaflo International), granting Navamedic the exclusive rights to market and distribute Vitaflo International’s medical nutrition products across the Nordic region for an additional five years....

Omnämnda platser: Renewed, Navamedic, Oslo.